Search for: "Boehringer Ingelheim Corp."
Results 21 - 40
of 53
Sorted by Relevance
|
Sort by Date
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
10 Mar 2010, 5:22 am
(FDA Law Blog) US: Review and correction of patent term adjustment calculation made by the USPTO: Boehringer Ingelheim Pharma GmbH & Co. [read post]
18 Mar 2010, 2:30 am
Baxter Healthcare Corp. [read post]
1 Aug 2019, 8:30 am
Boehringer Ingelheim Corp., et al., a $150 million settlement with GlaxoSmithKline PLC, and a $190 million settlement with Aventis Pharmaceuticals, Inc. [read post]
1 Dec 2009, 9:45 am
Intervet Inc. and Boehringer Ingelheim Vetmedica, Inc. [read post]
6 Nov 2007, 5:55 am
Rosenbaum, District of MinnesotaNature of Suits: Consists of 58 actions against Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. arising from use of Mirapex, a treatment for Parkinson's disease, which alleged causes obsessive pleasure- and reward-seeking behavior, such as gambling.In re Kugel Mesh Hernia Patch Products Liability Litigation, MDL 1842Filed 2/28/07 and ordered to be transferred on 6/22/2007Transferee Judge and Court: Mary H. [read post]
14 Jul 2010, 6:47 pm
Boehringer Ingelheim Pharma (EPLAW) Plavix (Clopidogrel) – US: Apotex’s second request for re-examination of Plavix patent denied by USPTO (Patent Docs) Tarka (Trandolapril, Verapamil) – Sanofi, Abbott successfully request sanctions against Glenmark in Tarka dispute (Patent Docs) [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
10 Jun 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Afro-Indian anti-counterfeit legislation debate; Legislation prompts India to send delegation to Africa (Spicy IP) (Afro-IP) (Afro-IP) Drug seizures in Frankfurt spark fears of EU-wide pattern (Intellectual Property Watch) General Broad plan on IP, innovation in developing countries approved at WHO (Intellectual Property Watch) World… [read post]
22 Jan 2008, 5:33 am
Boehringer Ingelheim Corp. [read post]
10 Jun 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Afro-Indian anti-counterfeit legislation debate; Legislation prompts India to send delegation to Africa (Spicy IP) (Afro-IP) (Afro-IP) Drug seizures in Frankfurt spark fears of EU-wide pattern (Intellectual Property Watch) General Broad plan on IP, innovation in developing countries approved at WHO (Intellectual Property Watch) World… [read post]
2 Nov 2012, 11:58 am
Boehringer Ingelheim Pharmaceuticals, Inc., 2009 WL 702007, at *3-4 (D. [read post]
13 May 2010, 4:58 pm
(FDA Law Blog) US: Divisional of a divisional: Avoid terminal disclaimers: CAFC denies en banc rehearing in Boehringer Ingelheim International GMBH v. [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
14 Jun 2010, 1:07 pm
That decision was challenged in court, see Boehringer Ingelheim Corp. v. [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US:… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US:… [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
4 Sep 2018, 7:00 am
Boehringer Ingelheim Pharmaceuticals, Inc., 892 F.3d 1264 (D.C. [read post]
